BRIEF-Forward Pharma Appeals The Decision Of The Opposition Division To Revoke The EP2801355 Patent


May 7 (Reuters) – Forward Pharma A/S:

* FORWARD PHARMA APPEALS THE DECISION OF THE OPPOSITION DIVISION TO REVOKE THE EP2801355 PATENT

* FORWARD PHARMA A/S – COMPANY HAS UNTIL AUGUST 2, 2018 TO SUBMIT ITS DETAILED GROUNDS OF APPEAL Source text for Eikon: Further company coverage:



Source link

Leave a Reply

Your email address will not be published.